Published in Tex Heart Inst J on January 01, 2005
TandemHeart insertion via a femoral arterial GORE-TEX graft conduit in a high-risk patient. Tex Heart Inst J (2008) 0.85
Percutaneous ventricular assist during aortic valvuloplasty: potential application to the deployment of aortic stent-valves. Tex Heart Inst J (2007) 0.83
Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation (2002) 8.51
Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet (2000) 2.68
Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol (2004) 2.20
Percutaneous aortic valve replacement: an experimental study. I. Studies on implantation. J Thorac Cardiovasc Surg (2002) 1.86
Clinical introduction of the Tandemheart, a percutaneous left ventricular assist device, for circulatory support during high-risk percutaneous coronary intervention. Int J Cardiovasc Intervent (2003) 1.39
Hemodynamic support with a percutaneous left ventricular assist device during stenting of an unprotected left main coronary artery. Tex Heart Inst J (2004) 1.38
Transcatheter implantation of a bovine valve in pulmonary position: a lamb study. Circulation (2000) 1.29
Steps toward percutaneous aortic valve replacement. Circulation (2002) 1.27
Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. J Am Coll Cardiol (1995) 1.27
Retrograde percutaneous aortic valve implantation for critical aortic stenosis. Catheter Cardiovasc Interv (2005) 0.96
First human case of retrograde transcatheter implantation of an aortic valve prosthesis. Tex Heart Inst J (2005) 0.86
Aortic valve disease: current recommendations. Curr Cardiol Rep (2004) 0.84
Percutaneous aortic valve replacement: will we get there? Heart (2001) 0.80
The treatment of aortic stenosis: is valvuloplasty ever an alternative to surgery? J Interv Cardiol (1993) 0.79
Trials planned for testing nonsurgical approach to replacing heart valves. JAMA (2003) 0.79
Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med (2009) 12.77
Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med (2007) 7.15
Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation (2012) 3.24
Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure. Circulation (2003) 2.75
The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol (2010) 1.94
A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv (2009) 1.76
Extracorporeal membrane oxygenation as a bridge to emergency heart-lung transplantation in a patient with idiopathic pulmonary arterial hypertension. J Heart Lung Transplant (2008) 1.72
Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure. J Card Fail (2005) 1.66
Clinical experience with the TandemHeart percutaneous ventricular assist device. Tex Heart Inst J (2006) 1.62
Mechanical bridging to improvement in severe acute "nonischemic, nonmyocarditis" heart failure. Congest Heart Fail (2004) 1.56
Evaluation of myocardial function in patients with end-stage heart failure during support with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant (2005) 1.51
Atrial fibrillation after cardiac transplantation: experience in 498 consecutive cases. Ann Thorac Surg (2008) 1.46
The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J Interv Cardiol (2013) 1.46
Use of the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention. J Invasive Cardiol (2006) 1.43
First clinical use of the redesigned HeartMate II left ventricular assist system in the United States: a case report. Tex Heart Inst J (2004) 1.40
Balloon Aortic Valvuloplasty in the Transcatheter Aortic Valve Replacement Era. J Invasive Cardiol (2016) 1.40
Endomyocardial nodular calcification as a cause of heart failure. Cardiovasc Pathol (2010) 1.40
TandemHeart as a rescue therapy for patients with critical aortic valve stenosis. Ann Thorac Surg (2009) 1.39
Lung cancer after heart transplantation: a 17-year experience. Ann Thorac Surg (2005) 1.39
Is the patient on this team? Int J Radiat Oncol Biol Phys (2003) 1.38
Hemodynamic support with a percutaneous left ventricular assist device during stenting of an unprotected left main coronary artery. Tex Heart Inst J (2004) 1.38
Percutaneous circulatory support in cardiogenic shock: interventional bridge to recovery. Circulation (2012) 1.22
Hemodynamics and patient safety during pump-off studies of an axial-flow left ventricular assist device. J Heart Lung Transplant (2006) 1.19
Incidental diagnosis of interrupted aortic arch in a 72-year-old man. Tex Heart Inst J (2009) 1.14
Mechanical circulatory support for advanced heart failure: where does it stand in 2003? Circulation (2003) 1.09
Long-term outcome of patients treated with repeat percutaneous coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosis. Circulation (2002) 1.08
Prolonged Venovenous Extracorporeal Membrane Oxygenation in a Patient With Acute Respiratory Distress Syndrome. ASAIO J (2016) 1.07
In vivo evaluation of the HeartWare centrifugal ventricular assist device. Tex Heart Inst J (2007) 1.04
Insights into functional bacterial diversity and its effects on Alpine bog ecosystem functioning. Sci Rep (2013) 1.03
The TandemHeart as a bridge to a long-term axial-flow left ventricular assist device (bridge to bridge). Tex Heart Inst J (2008) 1.02
Unprotected left main stent placement in a patient with Takayasu's arteritis: an unusual solution for an unusual disease. Tex Heart Inst J (2006) 1.01
Fatal pulmonary microthrombi during surgical therapy for end-stage heart failure: possible association with antifibrinolytic therapy. J Thorac Cardiovasc Surg (2006) 0.98
A felt plug simplifies left ventricular assist device removal after successful bridge to recovery. J Heart Lung Transplant (2007) 0.98
Percutaneous ventricular assist device support in a patient with a postinfarction ventricular septal defect. Tex Heart Inst J (2008) 0.97
A successful anticoagulation protocol for the first HeartMate II implantation in the United States. Tex Heart Inst J (2005) 0.97
Usefulness of percutaneous left ventricular assist device as a bridge to recovery from myocarditis. Am J Cardiol (2007) 0.96
Is native aortic valve commissural fusion in patients with long-term left ventricular assist devices associated with clinically important aortic insufficiency? J Heart Lung Transplant (2006) 0.94
Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure. J Card Fail (2008) 0.94
Continuous aortic flow augmentation: a pilot study of hemodynamic and renal responses to a novel percutaneous intervention in decompensated heart failure. Circulation (2005) 0.93
Relations among heart failure severity, left ventricular loading conditions, and repolarization length in advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol (2003) 0.93
Correlation of periprocedural systolic blood pressure changes with neurological events in high-risk carotid stent patients. J Endovasc Ther (2002) 0.92
Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation. J Heart Lung Transplant (2003) 0.92
Initial clinical experience with the HeartMate II axial-flow left ventricular assist device. Tex Heart Inst J (2007) 0.91
Peripheral vascular reactivity in patients with pulsatile vs axial flow left ventricular assist device support. J Heart Lung Transplant (2006) 0.90
The effect of LVAD aortic outflow-graft placement on hemodynamics and flow: Implantation technique and computer flow modeling. Tex Heart Inst J (2005) 0.90
Images in cardiovascular medicine. Percutaneous heart valve in the chronic in vitro testing model. Circulation (2002) 0.90
Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation. J Heart Lung Transplant (2008) 0.89
Significance of anaemia in patients with advanced heart failure receiving long-term mechanical circulatory support. Eur J Heart Fail (2009) 0.88
Brain natriuretic peptide levels and response to cardiac resynchronization therapy in heart failure patients. Congest Heart Fail (2006) 0.88
A less invasive approach to axial flow pump insertion. J Heart Lung Transplant (2008) 0.88
Percutaneous closure of a left ventricular pseudoaneurysm in a high-risk surgical candidate. Tex Heart Inst J (2012) 0.88
Preclinical testing of the Levitronix Ultramag pediatric cardiac assist device in a lamb model. ASAIO J (2007) 0.86
First human case of retrograde transcatheter implantation of an aortic valve prosthesis. Tex Heart Inst J (2005) 0.86
Left ventricular electromechanical mapping: preliminary evidence of electromechanical changes after successful coronary intervention. Am Heart J (2002) 0.85
Extracorporeal membrane oxygenation using the TandemHeart System's catheters. Tex Heart Inst J (2009) 0.84
How do we manage cardiopulmonary bypass coagulopathy? Transfusion (2014) 0.84
QTc interval prolongation predicts postoperative mortality in heart failure patients undergoing surgical revascularization. Tex Heart Inst J (2006) 0.84
Induced pulsation of a continuous-flow total artificial heart in a mock circulatory system. J Heart Lung Transplant (2010) 0.83
VAMMPIRE: a matched molecular pairs database for structure-based drug design and optimization. J Med Chem (2013) 0.83
Patients with severe chronic kidney disease benefit from early revascularization after acute coronary syndrome. Int J Cardiol (2013) 0.83
Increased leukocyte-platelet interactions during circulatory support with left ventricular assist devices. ASAIO J (2009) 0.83
Large pulmonary arteriovenous malformation diagnosed by cardiovascular magnetic resonance. Tex Heart Inst J (2011) 0.83
Location and density of alpha- and beta-adrenoreceptor sub-types in myocardium after mechanical left ventricular unloading. J Heart Lung Transplant (2008) 0.83
Percutaneous ventricular assist device and extracorporeal membrane oxygenation support in a patient with postinfarction ventricular septal defect and free wall rupture. Heart Surg Forum (2013) 0.83
Use of a percutaneous ventricular assist device for treatment of cardiogenic shock due to critical aortic stenosis. Tex Heart Inst J (2006) 0.82
Differentiating ST-elevation myocardial infarction from nonischemic ST-elevation in patients with chest pain. Am J Cardiol (2011) 0.82
Circular air-filled space in the aortic knob: a rare radiologic finding. Tex Heart Inst J (2014) 0.82
PleurX catheter for the management of refractory pleural effusions in congestive heart failure. Tex Heart Inst J (2009) 0.82
Intravenous milrinone in treatment of advanced congestive heart failure. Tex Heart Inst J (2003) 0.82
Reduced heterogeneity of muscle deoxygenation during heavy bicycle exercise. Med Sci Sports Exerc (2005) 0.82
Effects of a novel immune modulation therapy in patients with advanced chronic heart failure: results of a randomized, controlled, phase II trial. J Am Coll Cardiol (2004) 0.82
Noninvasive determination of exercise-induced vasodilation during bicycle exercise using near infrared spectroscopy. Med Sci Monit (2009) 0.81
Short QT interval and atrial fibrillation in patients without structural heart disease. J Am Coll Cardiol (2006) 0.81
Bridge to transplantation with the TandemHeart: bending the indications in a chronic aortic dissection patient with postcardiotomy shock. Tex Heart Inst J (2008) 0.81
Clinical experience with the TandemHeart percutaneous ventricular assist device as a bridge to cardiac transplantation. Tex Heart Inst J (2008) 0.81
Primary Cardiac Sarcoidosis with Syncope and Refractory Atrial Arrhythmia: A Case Report and Review of the Literature. Tex Heart Inst J (2016) 0.80
Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial). Am J Cardiol (2002) 0.80
Numerical characterization of hemodynamics conditions near aortic valve after implantation of Left Ventricular Assist Device. Math Biosci Eng (2011) 0.80
Ex vivo resuscitation of adult pig hearts. Tex Heart Inst J (2003) 0.80
Biventricular support with the Jarvik 2000 ventricular assist device in a calf model of pulmonary hypertension. ASAIO J (2004) 0.80
Review: auricular chondrocytes - from benchwork to clinical applications. In Vivo (2009) 0.80
Prognostic value of the QTc interval after cardiac transplantation. J Heart Lung Transplant (2005) 0.80
Chromium supplementation shortens QTc interval duration in patients with type 2 diabetes mellitus. Am Heart J (2005) 0.80
Current status of percutaneous ventricular assist devices for cardiogenic shock. Curr Opin Cardiol (2011) 0.79
Percutaneous ventricular assist device placement during active cardiopulmonary resuscitation for severe refractory cardiogenic shock after acute myocardial infarction. Tex Heart Inst J (2007) 0.79
Thirty-five years of mechanical circulatory support at the Texas Heart Institute: an updated overview. Tex Heart Inst J (2005) 0.79